Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RPID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 17.75M
March 31, 2026 20.40M
December 31, 2025 33.21M
September 30, 2025 44.33M
June 30, 2025 54.54M
March 31, 2025 65.49M
December 31, 2024 75.35M
September 30, 2024 84.37M
June 30, 2024 94.59M
March 31, 2024 105.94M
December 31, 2023 117.99M
September 30, 2023 127.79M
Date Value
June 30, 2023 139.63M
March 31, 2023 152.44M
December 31, 2022 164.17M
September 30, 2022 179.02M
June 30, 2022 194.97M
March 31, 2022 207.07M
December 31, 2021 220.98M
September 30, 2021 234.74M
June 30, 2021 71.31M
March 31, 2021 82.78M
December 31, 2020 24.82M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.363B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Danaher Corp. 52.58B
Harvard Bioscience, Inc. 7.418M

Shareholders Equity (Quarterly) Related Metrics